Aug 3, 2026 07:00AM
Aug 3, 2026 07:00AM
Jun 22, 2026 09:00AM
Jun 22, 2026 09:00AM
Jun 17, 2026 09:00AM
May 26, 2026 08:01AM
May 26, 2026 08:00AM Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting
May 14, 2026 08:00AM
May 14, 2026 08:00AM
Apr 30, 2026 08:03AM
Apr 30, 2026 08:00AM
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM
Apr 22, 2026 07:01AM Genprex abstract selected for 2026 ASCO meeting on lung cancer therapy
Apr 22, 2026 07:00AM
Apr 21, 2026 07:01AM
Apr 21, 2026 07:00AM
Apr 20, 2026 07:01AM
Apr 20, 2026 07:00AM
Mar 18, 2026 07:00AM
Mar 18, 2026 07:00AM Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
Mar 10, 2026 07:00AM
Feb 23, 2026 08:02AM
Feb 23, 2026 08:00AM
Feb 10, 2026 08:00AM
Feb 10, 2026 08:00AM
Jan 7, 2026 07:00AM
Jan 6, 2026 07:01AM Genprex reports preclinical data for diabetes gene therapy GPX-002
Jan 6, 2026 07:00AM
Nov 24, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 19, 2025 07:00AM
Nov 18, 2025 07:00AM
Nov 18, 2025 07:00AM
Nov 4, 2025 07:02AM GENPREX receives European patent intent for cancer gene therapy combination
Nov 4, 2025 07:00AM
Oct 28, 2025 11:20AM
Oct 28, 2025 11:19AM
Oct 28, 2025 07:00AM
Oct 28, 2025 07:00AM
Oct 23, 2025 08:12AM
Oct 23, 2025 08:12AM Genprex Announces Registered Direct Offering of up to $8.1 Million Priced At-The-Market Under Nasdaq Rules
Oct 23, 2025 07:02AM
Oct 23, 2025 07:00AM
Oct 14, 2025 07:00AM
Sep 2, 2025 08:30AM
Aug 18, 2025 09:29AM
Aug 18, 2025 09:29AM
Aug 4, 2025 08:31AM Genprex issues stockholder letter with 2025 corporate update
Aug 4, 2025 08:30AM

328,333 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All